Share
Scott Burger
AngioInsight, Inc., a trailblazer in medical imaging technology, has named Scott Burger as its new Chief Executive Officer (CEO).
With more than 20 years of leadership experience in the healthcare and medtech industries, Burger is set to drive the company’s next stage of innovation and strategic growth.
Burger has held key executive roles at several leading healthcare organizations, including Elucid, CorVista Health, HeartFlow, and Johnson & Johnson. Throughout his career, he has demonstrated a strong ability to scale businesses, advance cutting-edge technologies, and deliver exceptional financial results.
His strategic insight and comprehensive understanding of the healthcare ecosystem align seamlessly with AngioInsight’s vision to transform the diagnosis of cardiovascular and microvascular disease within the cath lab.
In his new role, Burger will oversee the acceleration of AngioInsight’s clinical and product development initiatives and expand its market footprint. A major milestone in this journey is the upcoming launch of the INSIGHT|AI pivotal clinical study, spearheaded by Dr. Todd Villines of the University of Virginia.
With Scott Burger at the helm, AngioInsight is well-positioned to bring its breakthrough imaging solutions closer to clinical adoption and improve patient outcomes globally.
.webp "RWJBarnabas Health Appoints Jonathan P. Kyriacou as President and CEO of Jersey City Medical Center")
